Status:
COMPLETED
Investigating Age-Related Macular Degeneration
Lead Sponsor:
National Eye Institute (NEI)
Conditions:
Age-Related Macular Degeneration
Eligibility:
All Genders
50+ years
Brief Summary
Age-related macular degeneration (ARMD) affects older Americans and can lead to irreversible blindness. Although the cause if ARMD is unclear, it appears to be a condition that is affected by both gen...
Detailed Description
Age-related macular degeneration (AMD) is a leading cause of visual impairment in the United States. Available evidence suggests that AMD is a complex disorder with a significant genetic component as ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- All Amish individuals, ages 50 and older, who either respond in the affirmative to the letter of invitation or are self-referred to the Amish clinic for participation in the AMD study, will be eligible.
- EXCLUSION CRITERIA:
- Individuals who decline participation, who are unwilling to sign the Consent Form, and who are not recognized by the Amish as being Amish will be excluded.
- There are no clinical inclusion/exclusion criteria.
Exclusion
Key Trial Info
Start Date :
June 20 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 4 2012
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT00342251
Start Date
June 20 2003
End Date
April 4 2012
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104-6056